Fundz

Chemomab Therapeutics Ltd. reported raising $45.4 Million in an initial SEC Form D filing, from an offering of $45.4 Million

PUBLIC · CMMBMar 30, 2021

Amount Raised

$45.4 Million

$45.4 Million sold, per SEC Form D (first sale Mar 30, 2021)

Round Type

Venture

Tel AvivBiotechnologyHealth CareTherapeutics

Quick answer

Chemomab Therapeutics Ltd raised $45.4 Million in a funding round, dated March 30, 2021. Chemomab Therapeutics Ltd is based in Tel Aviv, Tel Aviv District, Israel.

How much did Chemomab Therapeutics Ltd raise?
Chemomab Therapeutics Ltd raised $45.4 Million in a funding round on March 30, 2021.
What does Chemomab Therapeutics Ltd do?
Chemomab is a clinical stage biotechnology company discovering and developing innovative therapeutics for fibro-inflammatory diseases with high unmet need.
Where is Chemomab Therapeutics Ltd based and how big is it?
Chemomab Therapeutics Ltd is based in Tel Aviv, Tel Aviv District, Israel. Fundz records about 20 employees.
Who are the decision-makers at Chemomab Therapeutics Ltd?
Fundz holds 1 contact at Chemomab Therapeutics Ltd. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Chemomab Therapeutics Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Eikon Therapeutics raised $103M on May 13, 2021.
  • Nuvalent raised $135M on May 12, 2021.
  • Nuvalent raised $135M (Series B) on May 11, 2021.
  • Immunome Inc. raised $27M on May 11, 2021.
  • Eikon Therapeutics raised $148M (Series A) on May 5, 2021.
  • Revelation Biosciences raised $5.1M on May 4, 2021.

Who to call at Chemomab Therapeutics Ltd, and when

A new round usually means Chemomab Therapeutics Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Chemomab Therapeutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Chemomab Therapeutics Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Chemomab Therapeutics Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Chemomab Therapeutics Ltd

Location

KIRYAT ATIDIM, BUILDING 7

Tel Aviv, Tel Aviv District, Israel

About

Chemomab is a clinical stage biotechnology company discovering and developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique and pivotal role of the chemokine CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to neutralize CCL24 activity. In preclinical and clinical studies to date, CM-101 appears safe, with the potential to treat multiple severe and life-threatening fibro-inflammatory diseases. Chemomab has reported encouraging results from a Phase 2 liver fibrosis study in NASH patients and an investigator study in patients with severe lung injury. A Phase 2 trial in primary sclerosing cholangitis patients is ongoing. For more information on Chemomab, visit chemomab.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Chemomab Therapeutics Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at Chemomab Therapeutics Ltd. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Chemomab Therapeutics Ltd's next move

See what Strategic adds

Chemomab Therapeutics Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.